Additionally, the guidelines recognize the increased risk of euglycemic ketoacidosis associated with sodium-glucose co-transporter 2 (SGLT2) inhibitors, a class of medications used in diabetes ...
We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication. Research Design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback